Insulin Enhances the Viability of Doxorubicin-Exposed Luminal A Breast Cancer T-47D Cells
Lombok Medical Journal · 20.08.2026 · 5 (3) · 149-157
DOI: 10.29303/tv98zw69 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lombok Medical Journal, online erschienen am 20.08.2026. Verfasst von Fadhilla Resendryana Esthya und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Breast cancer is one of the most common cancers worldwide, with a high incidence rate. Doxorubicin is a chemotherapeutic agent used in breast cancer management. Nevertheless, chemoresistance remains a major challenge in breast cancer chemotherapy. Insulin contributes to chemoresistance through its mitogenic and prosurvival activities. To date, studies evaluating the effect of insulin on the viability of Luminal A breast cancer cells (T-47D) under doxorubicin exposure remain limited. This study aimed to analyse the effect of insulin supplementation on the viability of Luminal A breast cancer cells (T-47D) exposed to doxorubicin. An in vitro experimental study was conducted using T-47D cells treated with doxorubicin at various concentrations (3.13, 6.25, 12.5, 25, 50, and 100 μg/mL), with and without insulin supplementation. Cell viability was assessed using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and analysed using a paired-samples t-test. T-47D cells receiving insulin supplementation showed higher viability than those without insulin across all tested doxorubicin concentrations, with statistically significant differences (p < 0.05). The fold change in viability between the insulin and non-insulin groups increased with rising doxorubicin concentrations. In conclusion, insulin affects the viability of Luminal A breast cancer T-47D cells exposed to doxorubicin, indicating reduced cellular sensitivity to the cytotoxic effects of doxorubicin.
Zitieren
APA
Esthya, F. R., Padauleng, N., & Prihatina, L. M. (2026). Insulin Enhances the Viability of Doxorubicin-Exposed Luminal A Breast Cancer T-47D Cells. Lombok Medical Journal, 5(3), 149-157. https://doi.org/10.29303/tv98zw69
Vancouver
Esthya FR, Padauleng N, Prihatina LM. Insulin Enhances the Viability of Doxorubicin-Exposed Luminal A Breast Cancer T-47D Cells. Lombok Medical Journal. 2026;5(3):149-157. doi:10.29303/tv98zw69
BibTeX
@article{Esthya2026,
author = {Esthya, Fadhilla Resendryana and Padauleng, Novrita and Prihatina, Lale Maulin},
title = {Insulin Enhances the Viability of Doxorubicin-Exposed Luminal A Breast Cancer T-47D Cells},
journal = {Lombok Medical Journal},
year = {2026},
volume = {5},
number = {3},
pages = {149--157},
doi = {10.29303/tv98zw69}
}
EUVIMED